Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 18034

Страница 9 из 1804

Трехлетние результаты стентирования позвоночных артерий у пациентов с бессимптомным течением хронической ишемии головного мозга
Шугушев З.Х., Карасев С.М., Максимкин Д.А.
with atherosclerotic stenosis of the vertebral arteries as a method of secondary prevention of cerebrovascular
Cerebrovascular debut of arrhythmogenic right ventricular cardiomyopathy in children
Kantemirova M.G., Gorbunov A.V., Talalaev A.G., Bernikov S.Y., Novikova Y.Y., Korovina O.A., Ovsyannikov D.Y., Koltunov I.E.
wall. Sometimes ARVD is asymptomatic for a long time. Often a manifestation of the disease is sudden
Психопатологические расстройства при хронической ишемии мозга: возможности профилактики
Котова О.В., Зуйкова Н.Л., Палин А.В., Фролова В.И., Гушанская Е.В., Салынцев И.В., Медведев В.Э.
, somatogenic asthenia in patient with chronic cerebral ischemia (dyscirculatory encephalopathy, cerebrovascular
Study the possibility of adaptation among patients in dependence from housing region
Markin S.P., Chizhov A.Ya.
of patients with cerebrovascular disease. Fixing the physical methods of treatment in sanatorium necessary
STROKE PROPHYLAXIS WITH CORTEXIN
Markin S.P., Chizfiov A.Ya., Borisov V.A.
Cortexin was used in prophylaxis of stroke among patients with cerebrovascular diseases. A course
Molecular markers of ischemic stroke
Golubev A.M., Petrova M.V., Grechko A.V., Zakharchenko V.E., Kuzovlev A.N., Ershov A.V.
suffering from cerebrovascular disorders of ischemic origin. Neuron-specific enolase, brain
Pathogenic subtypes of Ischemic stroke In patients with atrial fibrillation
Alieva M., Geraskina L., Burzhunova M., Garabova N., Fonyakin A.
Predictors ofCardiovascular Complications after Ischemic stroke (prospective cohort study)
Alieva M., Geraskina L., Fonyakin A., Burzhunova M., Garabova N.
How to Use SNP-TATA-Comparator to Find a Significant Change in Gene Expression Caused by the Regulatory SNP of This Gene's Promoter via a Change in Affinity of the TATA-Binding Protein for This Promoter
Ponomarenko M.
The use of biomedical SNP markers of diseases can improve effectiveness of treatment. Genotyping
The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care
Gusev E. I.
The new coronavirus SARS-CoV-2 and the disease it causes COVID-19 involves not only respiratory

Страница 9 из 1804

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core